This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TRADE NEWS: Agilent Technologies Introduces SureSelectQXT Target Enrichment Kits For Same-Day Sample-to-Sequencing

Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect QXT Reagent Kit, a revolutionary next-generation sequencing target enrichment solution that produces sample-to-sequencing-ready libraries in just seven hours with only 50 ng of input gDNA.

Designed to meet the exacting needs of clinical researchers for a fast, easy, same-day sample-to-sequencing workflow, SureSelect QXT kits are three times faster than existing transposase-based methods and require 30 percent less hands-on time. They are optimized for use with samples of limited availability and provide superior coverage of genomic targets for confident variant calling. Combined with the fastest sequencers on the market, these kits make sample-to-data in 24 to 36 hours a reality.

“We are excited to provide this fast, powerful new target enrichment solution to the clinical research community,” said Victor Fung, senior director of global marketing for Agilent’s Diagnostics and Genomics Division. “With SureSelect QXT Reagent kits, researchers can quickly analyze exomes or target-specific genes with superior variant calling accuracy, and go from sample to sequencing in the same day.”

SureSelect QXT kits’ unprecedented speed is achieved by coupling transposase-based library preparation with major advancements in hybridization chemistry, significantly decreasing hybridization time from 16 hours to 90 minutes while maintaining high performance. The kits’ proven hybridization technology enables the sensitivity and specificity required for the complete and accurate variant analysis of exomes or custom genomic regions. The kits are complemented by an extensive portfolio of target enrichment solutions for library preparation, capture, automation, quality control and data analysis needs.

Agilent’s SureSelect portfolio is the industry’s leading target enrichment solution. With reagents that address needs from every step of the sequencing workflow, SureSelect enables a complete solution for researchers to quickly and easily analyze specific regions of the genome, transcriptome and methylome. As part of the complete solution, SureSelect is supported by SureDesign software that enables custom capability; Bravo automation platforms that enable reproducibility and high-throughput sample processing; and SureCall software that enables quick, easy, streamlined analysis of genomic regions of interest.

For more information about SureSelect QXT visit:

About Agilent in Genomics

Agilent Technologies is a global leader in target enrichment solutions for next-generation sequencing and genomic microarrays. By synthesizing custom complex mixtures of long oligonucleotides, SureSelect and HaloPlex target enrichment solutions enable researchers to identify genomic regions of interest for focused, cost-effective variant profiling, with workflows that generate sequencing-ready libraries in just one day. Agilent’s unique manufacturing technology is the foundation for Agilent’s genomics portfolio which includes SurePrint technology for accurate genome-wide measurement of gene expression, arrayCGH for combined copy number assessment with SNP information, and SureFISH, for highly sensitive and specific oligonucleotide fluorescent in-situ hybridization. Agilent also offers a microfluidic Bioanalyzer and TapeStation with complementary reagents and software for sample quantitation and quality assessment. For more information visit Agilent Genomics.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at

On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs